Collaborative Fund Advisors’s Quest Diagnostics DGX Stock Holding History

Collaborative Fund Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$423K	Buy	+1,998	New	+$392K	0.25%	122

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Collaborative Fund Advisors's DGX Position: Q2 2026 in Review

Collaborative Fund Advisors opened a new position in Quest Diagnostics (DGX) in Q2 2026: 1,998 shares worth $423K. The stake represents 0.25% of the portfolio and ranks #122 among its holdings.

1,098 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Collaborative Fund Advisors held 1,998 shares of Quest Diagnostics worth $423K as of Q2 2026.
Quest Diagnostics was a new Collaborative Fund Advisors position in Q2 2026.
Quest Diagnostics made up 0.25% of Collaborative Fund Advisors's portfolio in Q2 2026, its #122 holding.
1,098 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Collaborative Fund Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.